ReviewMolecular and clinical oncology2025

Anti‑HER2‑targeted therapies for the treatment of advanced HER2‑positive breast cancer with brain metastases (Review).

Zhangyan Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.